Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Potential possibilities of monitoring the procalcitonin concentration during antibacterial therapy of lower respiratory tract infections

Лазарева Н. Б., Журавлева М. В., Прокофьев А. Б., Ших Е. В.
Антибиотики и химиотерапия
Т. 63, Вып. 1-2, С. 32-37
Опубликовано: 2018
Тип ресурса: Статья
Аннотация:
The growing level of resistance of microorganisms requires a critical reduction in cases of unreasonable use of antibiotics and a reduction in the overall duration of antibiotic therapy. Controlled clinical trials conducted in recent years have confirmed the high effectiveness of the use of the procalcitonin test (B'R'À-H'M'S PCT™) in reducing the occurrence of unjustified prescribing of antibiotic therapy and reducing its duration.In this regard, procalcitonin test promotes the personalization of approaches to antibiotic therapy. It is possible to significantly reduce the frequency of empirical antibiotic therapy in low-risk situations (bronchitis, exacerbation of COPD) by determining the level of procalcitonin (B-R-A'H-M-S PCT™). Monitoring the concentration of procalcitonin allows shortening of the duration of antibiotic therapy in more severe clinical situations (pneumonia, sepsis). © 2018 Media Sphera Publishing Group. All rights reserved.
Ключевые слова:
Antibacterial therapy; Procalcitonin; Respiratory tract infections
Язык текста: Русский
ISSN: 0235-2990
Лазарева Н. Б. Наталья Борисовна 1978-
Журавлева М. В. Марина Владимировна 1958-
Прокофьев А. Б. Алексей Борисович 1964-
Ших Е. В. Евгения Валерьевна 1962-
Lazareva N. B. Natal`ya Borisovna 1978-
Zhuravleva M. V. Marina Vladimirovna 1958-
Prokofyev A. B. Aleksej Borisovich 1964-
Shikh E. V. Evgeniya Valeryevna 1962-
Potential possibilities of monitoring the procalcitonin concentration during antibacterial therapy of lower respiratory tract infections
Текст визуальный непосредственный
Антибиотики и химиотерапия
Издательство ОКИ
Т. 63, Вып. 1-2 С. 32-37
2018
Статья
Antibacterial therapy Procalcitonin Respiratory tract infections
The growing level of resistance of microorganisms requires a critical reduction in cases of unreasonable use of antibiotics and a reduction in the overall duration of antibiotic therapy. Controlled clinical trials conducted in recent years have confirmed the high effectiveness of the use of the procalcitonin test (B'R'À-H'M'S PCT™) in reducing the occurrence of unjustified prescribing of antibiotic therapy and reducing its duration.In this regard, procalcitonin test promotes the personalization of approaches to antibiotic therapy. It is possible to significantly reduce the frequency of empirical antibiotic therapy in low-risk situations (bronchitis, exacerbation of COPD) by determining the level of procalcitonin (B-R-A'H-M-S PCT™). Monitoring the concentration of procalcitonin allows shortening of the duration of antibiotic therapy in more severe clinical situations (pneumonia, sepsis). © 2018 Media Sphera Publishing Group. All rights reserved.